25
Participants
Start Date
December 10, 2002
Primary Completion Date
September 23, 2004
Study Completion Date
September 22, 2008
buserelin
custirsen sodium
flutamide
conventional surgery
neoadjuvant therapy
British Columbia Cancer Agency - Vancouver Cancer Centre, Vancouver
Lead Sponsor
NCIC Clinical Trials Group
NETWORK